Espinoza Octavio bought LGND
August 12, 2026 · Form 4 insider transaction
Espinoza Octavio bought 16,179 shares of Ligand Pharmaceuticals Incorporated at $52.84 per share, a transaction worth $854.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,179
Price
$52.84
Total value
$854.9K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after43,875
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 13, 2026, in accordance with Rule 10b5-1.